Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer

Annals of Oncology

Volumn 17, Issue 11, 2006, Pages 1661-1664

  Berardi, R ^a   Braconi, C ^a   Mantello, G ^a   Scartozzi, M ^a   Del Prete, S ^a   Luppi, G ^b   Martinelli, R ^c   Fumagalli, M ^c   Valeri, G ^d   Bearzi, I ^d   Marmovale, C ^d   Grillo Ruggieri F ^a   Cascinu, S ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Anemia; Prognostic factors; Rectal cancer

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; HEMOGLOBIN; MITOMYCIN C; OXALIPLATIN;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOLOGY DEPARTMENT; RECTUM CANCER; RECTUM CARCINOMA; SURGICAL WARD; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBINS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 33750590704     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl285     Document Type: Article

References (26)

1. Faenza A, Cunsolo A, Selleri S et al. Correlation between plasma or blood transfusion and survival after curative surgery for colorectal cancer. Int Surg 1992; 77: 264-269.
2. Schwartz G. Ueber Desensibilisierung Gegen roentgen- und Radiumstrahlen. Munch Med Wochenschr 1909; 24: 1-2.
3. Hollaender A, Stapletone GE, Martin FL. X-ray sensitivity of E. coli as modified by oxygen tension. Nature 1951; 167: 103-104.
4. Teicher BA. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Hematol Oncol Clin North Am 1995; 9: 475-506.
5. Thews O, Kellehr DK, Vaupel P. Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 2001; 61: 1358.
6. Stueben G, Thews O, Pottgen C et al. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol 2001; 127: 346-350.
7. Harrison LB, Chadha M, Hill RJ et al. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002; 7: 492-508.
8. Thomas G. The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience. Semin Oncol 2001; 28: 60-65.
9. Obermeier A, Cheuk R, Horwood K et al. Cancer 2001; 92: 903-908.
10. Lee WR, Berkey B, Marcial V et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998; 42: 1069-1075.
11. Warde P, O'Sullivan B, Bristow RG et al. T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998; 41: 347-353.
12. Dubray B, Mosseri V, Brunin F et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study. Radiology 1996; 201: 553-558.
13. Fein DA, Lee WR, Hanln AR et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995; 13: 2077-2083.
14. Skladowski K, Tarnawski R, Maciejewski B et al. Clinical radiobiology of glottic T1 squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1999; 43: 101-106.
15. Lutterbach J, Guttenberger R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. Int J Radiat Oncol Biol Phys 2000; 48: 1345-1350.
16. Van Acht MJ, Hermans J, Box DE, Leer JW. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 1992; 23: 229-235.
17. Ong YK, Heng DM, Chung B et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer 2003; 39: 1535-1541.
18. Wagner W, Hermann R, Hartlapp J et al. Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 2000; 176: 73-80.
19. Werner-Wasik M, Scott C, Cox JD et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival. Int J Radiat Oncol Biol Phys 2000; 48: 1475-1482.
20. MacRae R, Shyr Y, Johnson D, Choy H. Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant. Radiother Oncol 2002; 64: 37-40.
21. Pradier O, Lederer K, Hille A et al. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: A phase II trial with special reference to the hemoglobin level as prognostic parameter. J Cancer Res Clin oncol 2005; 131: 261-269.
22. Robnett TJ, Machtay M, Hahn SM et al. Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients. Cancer J 2002; 8: 263-267.
23. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187-220.
24. Box B, Lindsey I, Wheeler JM et al. Neoadjuvant therapy for rectal cancer: Improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum 2005; 48: 1153-1160.
25. Shen JG, Cheong JH, Hyung WJ et al. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. J Surg Oncol 2005; 91: 126-130.
26. Glaser M, Millesi W, Kornek GV et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001; 50: 705-710.